search
Back to results

Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation

Primary Purpose

Primary Progressive Aphasia, Apraxia of Speech

Status
Recruiting
Phase
Early Phase 1
Locations
United States
Study Type
Interventional
Intervention
Transcranial direct current stimulation
Sponsored by
The University of Texas at Dallas
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Primary Progressive Aphasia

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 18 to 85 years of age
  • A formal diagnosis of primary progressive aphasia (nonfluent/agrammatic, semantic, logopenic variants or mixed) and/or progressive apraxia of speech
  • Capable of understanding and signing an informed consent. Medical information/history, as well as mental status exam and diagnosis provided by referring physician will determine whether or not a caregiver is required to be involved during this process.

Exclusion Criteria:

  • Has an implanted device, such as a pacemaker, metallic cranial implant, or a neurostimulator
  • Skull defects
  • Pregnant
  • A significant history of arrhythmia or epileptic seizures.
  • Not a native English speaker
  • Currently receiving speech-language intervention

Sites / Locations

  • The University of Texas at DallasRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Active tDCS treatment

Arm Description

This pilot study has one treatment arm with open-label treatment and will examine improvement of speech output, verbal fluency, and other cognitive deficits associated with primary progressive aphasia (PPA) and progressive apraxia of speech (PAOS), by utilizing 1 milliamp transcranial direct current stimulation (tDCS) active treatment applied to pre-supplementary motor area for 20 minutes over 10 sessions. There will be baseline testing, and follow up testing immediately after and 8 weeks after completion of treatment.

Outcomes

Primary Outcome Measures

The Controlled Oral Word Association Test
Evaluation of treatment differences in change on the Control Word Association Test Benton, L.A., Hamsher, K., & Sivan, A.B., (1994). Multilingual aphasia examination. Iowa City: AJA Associates.
Category Fluency
Evaluation of treatment differences in change on Category Fluency Benton, L.A., Hamsher, K., & Sivan, A.B., (1994). Multilingual aphasia examination. Iowa City: AJA Associates.
The Boston Naming Test
Evaluation of treatment differences in change on The Boston Naming Test (accuracy and speech latency) Kaplan, E., Goodglass, H., & Weintraub, S., (1983). Boston Naming Test (2nd ed.). Lea & Febiger: Philadelphia.
Spontaneous speech (content and fluency) of the Western Aphasia Battery-Revised
Evaluation of treatment differences in change on Spontaneous speech (content and fluency) of the Western Aphasia Battery-Revised Kertesz, Andrew. ( 1982). The Western aphasia battery. New York :Grune & Stratton.
The Apraxia battery for Adults - 2 (ABA - 2)
Evaluation of treatment differences in change on characteristics of articulation of the the Apraxia battery for Adults - 2 Dabul, B. L. (2000). Apraxia Battery for Adults (ABA-2) (2nd edn). Austin, TX: ProEd.

Secondary Outcome Measures

The Trail Making Test (Part A & B)
Evaluation of treatment differences in change on The Trail Making Test (Part A & B) Reitan, R.M., (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Percept. Motor Skill., 8, 271-276.
The Digit Span Forward & Backward
Evaluation of treatment differences in change on The Digit Span Forward & Backward Wechsler, D., (2008). Wechsler adult intelligence scale-Fourth Edition (WAIS-IV). San Antonio, TX: NCS Pearson.
The Digit Symbol Substitution Test
Evaluation of treatment differences in change on The Digit Symbol Substitution Test Wechsler, D., (2008). Wechsler adult intelligence scale-Fourth Edition (WAIS-IV). San Antonio, TX: NCS Pearson.
The Hopkins Verbal Learning Test-Revised
Evaluation of treatment differences in change on The Hopkins Verbal Learning Test-Revised Benedict, R. H. B., Schretlen, D., Groninger, L., & Brandt, J. (1998). The Hopkins verbal learning test-revised: Normative data and analysis of interform and test-retest reliability. Clinical Neuropsychologist, 12, 43-55.
The Rey-Osterrieth Complex Figure Test
Evaluation of treatment differences in change on The Rey-Osterrieth Complex Figure Test Rey, A. (1941). L'examen psychologique dans les cas d'encéphalopathie traumatique. (Les problems.). [The psychological examination in cases of traumatic encepholopathy. Problems.]. Archives de Psychologie, 28, 215- 285.

Full Information

First Posted
May 5, 2022
Last Updated
October 13, 2023
Sponsor
The University of Texas at Dallas
search

1. Study Identification

Unique Protocol Identification Number
NCT05368350
Brief Title
Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation
Official Title
Treating Primary Progressive Aphasia and Apraxia of Speech With High Definition Transcranial Direct Current Stimulation (HDtDCS-PPA/PAOS)
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 1, 2022 (Actual)
Primary Completion Date
June 30, 2024 (Anticipated)
Study Completion Date
June 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The University of Texas at Dallas

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes

5. Study Description

Brief Summary
The purpose of the study is to test whether low level electric stimulation, called transcranial Direct Current Stimulation (tDCS), on the part of the brain (i.e., pre-supplementary motor area) thought to aid in memory will improve speech and language difficulties in patients with primary progressive aphasia (PPA) and progressive apraxia of speech (PAOS). The primary outcome measures are neuropsychological assessments of speech and language functions, and the secondary measures are neuropsychological assessments of other cognitive abilities and electroencephalography (EEG) measures.
Detailed Description
This pilot study has one treatment arm with open-label treatment and will examine improvement of speech output, verbal fluency, and other cognitive deficits associated with primary progressive aphasia (PPA) and progressive apraxia of speech (PAOS), by utilizing 1 milliamp transcranial direct current stimulation (tDCS) active treatment applied to pre-supplementary motor area for 20 minutes over 10 sessions. There will be baseline testing, and follow up testing immediately after and 8 weeks after completion of treatment. All patients with a clinical diagnosis of PPA or PAOS will be assigned to one open-label group to receive active tDCS. Primary outcome speech and language measures, secondary neuropsychological and electroencephalography (EEG) measures, and pre-screening assessments for study medical history and contraindications for treatment will be collected prior to the treatment (i.e., baseline). Primary outcome speech and language functions measures and secondary neuropsychological and electroencephalography (EEG) measures will be collected after treatment session 10 and following treatment competition (i.e., 8-week).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Primary Progressive Aphasia, Apraxia of Speech

7. Study Design

Primary Purpose
Treatment
Study Phase
Early Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
12 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Active tDCS treatment
Arm Type
Experimental
Arm Description
This pilot study has one treatment arm with open-label treatment and will examine improvement of speech output, verbal fluency, and other cognitive deficits associated with primary progressive aphasia (PPA) and progressive apraxia of speech (PAOS), by utilizing 1 milliamp transcranial direct current stimulation (tDCS) active treatment applied to pre-supplementary motor area for 20 minutes over 10 sessions. There will be baseline testing, and follow up testing immediately after and 8 weeks after completion of treatment.
Intervention Type
Device
Intervention Name(s)
Transcranial direct current stimulation
Intervention Description
Other Names: tDCS 1 milliamp tDCS High definition tDCS High definition transcranial direct current stimulator, Neuroelectrics Starstim tES, SN E20200930-10 Transcranial direct current stimulation will be delivered via a Neuroelectrics Starstim tES. Stimulation will consist of 1 milliamp stimulation, with anodal stimulation delivered at electrode Fz (International 10/10 System for electroencephalography electrode placement) and electrodes F7, FP1, FP2, and F8 as returns. All electrodes are 1 cm diameter Ag/AgCl electrodes and make contact with the scalp via connective gel. Stimulation will linearly ramp up from 0 milliamps to 1 milliamp over 60 seconds, then remain at 1 milliamp of stimulation over 20 minutes, and finally ramping down at to 0 milliamps over 60 seconds.
Primary Outcome Measure Information:
Title
The Controlled Oral Word Association Test
Description
Evaluation of treatment differences in change on the Control Word Association Test Benton, L.A., Hamsher, K., & Sivan, A.B., (1994). Multilingual aphasia examination. Iowa City: AJA Associates.
Time Frame
Treatment change from Baseline to Immediate post, and 8 weeks post treatment completion.
Title
Category Fluency
Description
Evaluation of treatment differences in change on Category Fluency Benton, L.A., Hamsher, K., & Sivan, A.B., (1994). Multilingual aphasia examination. Iowa City: AJA Associates.
Time Frame
Treatment change from Baseline to Immediate post, and 8 weeks post treatment completion.
Title
The Boston Naming Test
Description
Evaluation of treatment differences in change on The Boston Naming Test (accuracy and speech latency) Kaplan, E., Goodglass, H., & Weintraub, S., (1983). Boston Naming Test (2nd ed.). Lea & Febiger: Philadelphia.
Time Frame
Treatment change from Baseline to Immediate post, and 8 weeks post treatment completion.
Title
Spontaneous speech (content and fluency) of the Western Aphasia Battery-Revised
Description
Evaluation of treatment differences in change on Spontaneous speech (content and fluency) of the Western Aphasia Battery-Revised Kertesz, Andrew. ( 1982). The Western aphasia battery. New York :Grune & Stratton.
Time Frame
Treatment change from Baseline to Immediate post, and 8 weeks post treatment completion.
Title
The Apraxia battery for Adults - 2 (ABA - 2)
Description
Evaluation of treatment differences in change on characteristics of articulation of the the Apraxia battery for Adults - 2 Dabul, B. L. (2000). Apraxia Battery for Adults (ABA-2) (2nd edn). Austin, TX: ProEd.
Time Frame
Treatment change from Baseline to Immediate post, and 8 weeks post treatment completion.
Secondary Outcome Measure Information:
Title
The Trail Making Test (Part A & B)
Description
Evaluation of treatment differences in change on The Trail Making Test (Part A & B) Reitan, R.M., (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Percept. Motor Skill., 8, 271-276.
Time Frame
Treatment change from Baseline to Immediate post, and 8 weeks post treatment completion.
Title
The Digit Span Forward & Backward
Description
Evaluation of treatment differences in change on The Digit Span Forward & Backward Wechsler, D., (2008). Wechsler adult intelligence scale-Fourth Edition (WAIS-IV). San Antonio, TX: NCS Pearson.
Time Frame
Treatment change from Baseline to Immediate post, and 8 weeks post treatment completion.
Title
The Digit Symbol Substitution Test
Description
Evaluation of treatment differences in change on The Digit Symbol Substitution Test Wechsler, D., (2008). Wechsler adult intelligence scale-Fourth Edition (WAIS-IV). San Antonio, TX: NCS Pearson.
Time Frame
Treatment change from Baseline to Immediate post, and 8 weeks post treatment completion.
Title
The Hopkins Verbal Learning Test-Revised
Description
Evaluation of treatment differences in change on The Hopkins Verbal Learning Test-Revised Benedict, R. H. B., Schretlen, D., Groninger, L., & Brandt, J. (1998). The Hopkins verbal learning test-revised: Normative data and analysis of interform and test-retest reliability. Clinical Neuropsychologist, 12, 43-55.
Time Frame
Treatment change from Baseline to Immediate post, and 8 weeks post treatment completion.
Title
The Rey-Osterrieth Complex Figure Test
Description
Evaluation of treatment differences in change on The Rey-Osterrieth Complex Figure Test Rey, A. (1941). L'examen psychologique dans les cas d'encéphalopathie traumatique. (Les problems.). [The psychological examination in cases of traumatic encepholopathy. Problems.]. Archives de Psychologie, 28, 215- 285.
Time Frame
Treatment change from Baseline to Immediate post, and 8 weeks post treatment completion.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 18 to 85 years of age A formal diagnosis of primary progressive aphasia (nonfluent/agrammatic, semantic, logopenic variants or mixed) and/or progressive apraxia of speech Capable of understanding and signing an informed consent. Medical information/history, as well as mental status exam and diagnosis provided by referring physician will determine whether or not a caregiver is required to be involved during this process. Exclusion Criteria: Has an implanted device, such as a pacemaker, metallic cranial implant, or a neurostimulator Skull defects Pregnant A significant history of arrhythmia or epileptic seizures. Not a native English speaker Currently receiving speech-language intervention
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Hsueh-Sheng Chiang, MD, PhD
Phone
469-708-4925
Email
hschiang@utdallas.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Jill Ritter, BS
Phone
469-708-4925
Email
jill.ritter@utdallas.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John Hart, MD
Organizational Affiliation
University of Texas at Dallas
Official's Role
Principal Investigator
Facility Information:
Facility Name
The University of Texas at Dallas
City
Dallas
State/Province
Texas
ZIP/Postal Code
75235
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jill Ritter, BS
Phone
469-708-4925
Email
jill.ritter@utdallas.edu

12. IPD Sharing Statement

Learn more about this trial

Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation

We'll reach out to this number within 24 hrs